Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Ho

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cancer Research|November 12, 2009
De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activationJi-Wei Liu, Ping Sun, Qiu Yan, et al.
Applied Biochemistry and Biotechnology|April 29, 2005
Industrial scale-up of pH-controlled liquid hot water pretreatment of corn fiber for fuel ethanol productionNathan S Mosier, Richard Hendrickson, Mark Brewer, et al.
Pediatric Health, Medicine and Therapeutics|February 27, 2020
Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile SpasmsLaura S Gold, Tara A Nazareth, Tzy-Chyi Yu, et al.
Mayo Clinic Proceedings|July 23, 2013
A decade of reversal: an analysis of 146 contradicted medical practicesVinay Prasad, Andrae Vandross, Caitlin Toomey, et al.
The American Journal of Gastroenterology|June 9, 2015
Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD ColitisKatherine J Hahn, Nancy Ho, Lynne Yockey, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2015
Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced functionAlyssa Mitson-Salazar, Yuzhi Yin, Daniel L Wansley, et al.
Journal of Pharmacological and Toxicological Methods|January 6, 2009
Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouseDarrick T Balu, Georgia E Hodes, Tiffany E Hill, et al.
Inflammatory Bowel Diseases|November 19, 2016
Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous DiseaseChengrui Huang, Suk See De Ravin, Adam R Paul, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 8, 2015
Gastrointestinal Features of Chronic Granulomatous Disease Found During EndoscopySajneet K Khangura, Natasha Kamal, Nancy Ho, et al.
Nature Genetics|November 8, 2016
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy numberJonathan J Lyons, Xiaomin Yu, Jason D Hughes, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cancer Research|November 12, 2009
De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activationJi-Wei Liu, Ping Sun, Qiu Yan, et al.
Applied Biochemistry and Biotechnology|April 29, 2005
Industrial scale-up of pH-controlled liquid hot water pretreatment of corn fiber for fuel ethanol productionNathan S Mosier, Richard Hendrickson, Mark Brewer, et al.
Pediatric Health, Medicine and Therapeutics|February 27, 2020
Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile SpasmsLaura S Gold, Tara A Nazareth, Tzy-Chyi Yu, et al.
Mayo Clinic Proceedings|July 23, 2013
A decade of reversal: an analysis of 146 contradicted medical practicesVinay Prasad, Andrae Vandross, Caitlin Toomey, et al.
The American Journal of Gastroenterology|June 9, 2015
Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD ColitisKatherine J Hahn, Nancy Ho, Lynne Yockey, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2015
Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced functionAlyssa Mitson-Salazar, Yuzhi Yin, Daniel L Wansley, et al.
Journal of Pharmacological and Toxicological Methods|January 6, 2009
Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouseDarrick T Balu, Georgia E Hodes, Tiffany E Hill, et al.
Inflammatory Bowel Diseases|November 19, 2016
Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous DiseaseChengrui Huang, Suk See De Ravin, Adam R Paul, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 8, 2015
Gastrointestinal Features of Chronic Granulomatous Disease Found During EndoscopySajneet K Khangura, Natasha Kamal, Nancy Ho, et al.
Nature Genetics|November 8, 2016
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy numberJonathan J Lyons, Xiaomin Yu, Jason D Hughes, et al.
Pageof 4